双鹭药业：参股公司长风药业预计于2025年10月8日在联交所挂牌上市

Core Viewpoint - The announcement indicates that Changfeng Pharmaceutical, a company in which Shuanglu Pharmaceutical holds a stake, is expected to officially list on the Hong Kong Stock Exchange on October 8, 2025, under the stock code 02652.HK [1] Summary by Relevant Categories Company Information - Shuanglu Pharmaceutical holds 15,165,700 shares in Changfeng Pharmaceutical, which is expected to represent 3.68% of the total shares post-issuance [1] - Changfeng Pharmaceutical plans to globally offer 41,198,000 shares at a price of HKD 14.75 per share [1] Market Impact - The listing of Changfeng Pharmaceutical is anticipated to enhance Shuanglu Pharmaceutical's visibility and potential market valuation [1]